Related Experiment Video

Updated: May 21, 2026

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening
15:28

A Microscopic Phenotypic Assay for the Quantification of Intracellular Mycobacteria Adapted for High-throughput/High-content Screening

Published on: January 17, 2014

[Ultrastructural changes in cells of mycobacteria affected by flurenizid derivatives]

O R Kulachkovs'kyĭ, O Z Zarichna, A V Sybirnyĭ

    Mikrobiolohichnyi Zhurnal (Kiev, Ukraine : 1993)
    |June 13, 2012
    PubMed

    Insights

    Antibacterial substances cause significant ultrastructural changes in mycobacteria, including cell disorganization and morphological alterations. These effects intensify with longer exposure and higher concentrations.

    Area of Science:

    • Microbiology
    • Cell Biology
    • Bacteriology

    Context:

    • Investigating the impact of antibacterial substances on mycobacterial cell structure.
    • Observing ultrastructural changes in mycobacteria under varying exposure times and concentrations.

    Purpose:

    • To document and analyze the morphological and ultrastructural alterations in mycobacteria induced by antibacterial agents.
    • To compare the effects of different exposure durations and concentrations of antibacterial substances on mycobacterial cells.

    Summary:

    • Exposure to antibacterial substances induced significant ultrastructural changes in mycobacteria, including nucleoid and cytoplasm disorganization, vacuole formation, and altered cell morphology.
    • Observed changes were more pronounced after 72 hours compared to 24 hours and intensified with increasing substance concentrations.
    • No significant differences were noted in the nature of changes across different antibacterial substances tested.

    Impact:

    • Provides detailed insights into the cellular mechanisms of antibacterial action against mycobacteria.
    • Contributes to understanding mycobacterial susceptibility and potential resistance pathways.
    • Informs the development of novel antibacterial strategies targeting mycobacterial ultrastructure.

    More Related Videos

    Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

    Assay Development for High-Throughput Drug Screening Against Mycobacteria

    Published on: October 25, 2024

    Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography07:42

    Analysis of the Lipid Composition of Mycobacteria by Thin Layer Chromatography

    Published on: April 16, 2021

    Related Concept Videos

    Inhibitors of Bacterial DNA Synthesis01:28

    Inhibitors of Bacterial DNA Synthesis

    Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
    Mechanism of Antibiotic Resistance in MRSA01:25

    Mechanism of Antibiotic Resistance in MRSA

    Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...